HK1223025A1 - 組織閉塞劑 - Google Patents

組織閉塞劑

Info

Publication number
HK1223025A1
HK1223025A1 HK16111269.3A HK16111269A HK1223025A1 HK 1223025 A1 HK1223025 A1 HK 1223025A1 HK 16111269 A HK16111269 A HK 16111269A HK 1223025 A1 HK1223025 A1 HK 1223025A1
Authority
HK
Hong Kong
Prior art keywords
occluding agent
tissue occluding
tissue
agent
occluding
Prior art date
Application number
HK16111269.3A
Other languages
English (en)
Inventor
高村健太郎
五條理志
小林智
Original Assignee
3-D Matrix Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42100586&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1223025(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 3-D Matrix Ltd filed Critical 3-D Matrix Ltd
Publication of HK1223025A1 publication Critical patent/HK1223025A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L17/00—Materials for surgical sutures or for ligaturing blood vessels ; Materials for prostheses or catheters
    • A61L17/06—At least partially resorbable materials
    • A61L17/10—At least partially resorbable materials containing macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/043—Proteins; Polypeptides; Degradation products thereof
    • A61L31/047—Other specific proteins or polypeptides not covered by A61L31/044 - A61L31/046
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/145—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/148—Materials at least partially resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/36—Materials or treatment for tissue regeneration for embolization or occlusion, e.g. vaso-occlusive compositions or devices
HK16111269.3A 2008-10-06 2016-09-26 組織閉塞劑 HK1223025A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2008259860 2008-10-06
JP2008316133 2008-12-11

Publications (1)

Publication Number Publication Date
HK1223025A1 true HK1223025A1 (zh) 2017-07-21

Family

ID=42100586

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16111269.3A HK1223025A1 (zh) 2008-10-06 2016-09-26 組織閉塞劑

Country Status (13)

Country Link
US (5) US10576123B2 (zh)
EP (5) EP4183425A1 (zh)
JP (4) JPWO2010041636A1 (zh)
KR (1) KR101670099B1 (zh)
CN (2) CN105435211A (zh)
BR (1) BRPI0920030B1 (zh)
ES (3) ES2694000T3 (zh)
HK (1) HK1223025A1 (zh)
PH (2) PH12017501278A1 (zh)
PL (1) PL3470093T3 (zh)
RU (2) RU2011118341A (zh)
SG (1) SG194405A1 (zh)
WO (1) WO2010041636A1 (zh)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9162005B2 (en) 2005-04-25 2015-10-20 Arch Biosurgery, Inc. Compositions for prevention of adhesions and other barrier applications
CN105435211A (zh) 2008-10-06 2016-03-30 三维肽胶株式会社 组织闭塞剂
US20140329914A1 (en) * 2011-09-02 2014-11-06 3-D Matrix Ltd. Amphiphilic Peptides for Thoracic Air Leakage Occlusion
US10905708B2 (en) 2011-09-07 2021-02-02 3-D Matrix, Ltd. MicroRNA-based methods and assays for osteocarcinoma
US11260072B2 (en) 2011-09-07 2022-03-01 3-D Matrix, Ltd. MicroRNA-based methods and assays for osteocarcinoma
CN102408575B (zh) * 2011-09-09 2013-02-13 南京大学 一种可注射多肽水凝胶的制备方法
US20150105336A1 (en) 2012-03-09 2015-04-16 3-D Matrix, Ltd. Mucosa-elevating agent
WO2014008400A2 (en) * 2012-07-06 2014-01-09 3-D Matrix, Inc. Fill-finish process for peptide solutions
EP2698162A1 (en) 2012-08-15 2014-02-19 Credentis AG Method for producing a composition for treating a tooth lesion
JP2016501066A (ja) * 2012-11-14 2016-01-18 株式会社スリー・ディー・マトリックス 血管塞栓システム
US10245011B2 (en) 2012-12-25 2019-04-02 Osaka University Hemostatic agent applicator
WO2014136081A1 (en) * 2013-03-06 2014-09-12 3D-Matrix Ltd. Surgical methods employing purified amphiphilic peptide compositions
CA2905182A1 (en) * 2013-03-14 2014-09-18 3-D Matrix, Ltd. Materials for gastrointestinal obstruction prevention
JP2016513523A (ja) * 2013-03-14 2016-05-16 株式会社スリー・ディー・マトリックス 胆汁漏の処置
CA2908136C (en) 2013-03-30 2021-06-29 Glytech, Inc. Sugar chain-polypeptide complex
JP6502352B2 (ja) 2013-08-22 2019-04-17 アーチ・バイオサージェリー・インコーポレイテッド 流体の移動を制御するための移植可能なメッシュ
EP2853256A1 (en) 2013-09-25 2015-04-01 Credentis AG Dental care product for tooth whitening
EP3049054B1 (en) 2013-09-25 2018-04-04 Credentis AG Dental care product for tooth whitening
JP2015142720A (ja) * 2013-12-27 2015-08-06 株式会社メニコン 止血材
US10245299B2 (en) 2014-03-10 2019-04-02 3-D Matrix, Ltd. Autoassembling peptides for the treatment of pulmonary bulla
WO2015136370A2 (en) 2014-03-10 2015-09-17 3-D Matrix, Ltd. Sterilization and filtration of peptide compositions
WO2015138473A1 (en) * 2014-03-10 2015-09-17 3-D Matrix, Ltd. Autoassembling peptides for the treatment of pulmonary leakage
US10654893B2 (en) * 2014-03-10 2020-05-19 3-D Matrix, Ltd. Self-assembling peptide compositions
ES2706492T3 (es) * 2014-03-10 2019-03-29 3 D Matrix Ltd Péptidos de autoensamblaje como agentes para la obstrucción bronquial
EP3124058A4 (en) * 2014-03-28 2017-11-29 Otsuka Chemical Co., Ltd. Hemostatic pharmaceutical composition
BR112016029518A2 (pt) * 2014-06-20 2018-06-19 3-D Matrix, Ltd. materiais e métodos para o enchimento de cavidades ósseas
JP6389013B2 (ja) * 2015-04-23 2018-09-12 ザ・ティムケン・カンパニーＴｈｅ Ｔｉｍｋｅｎ Ｃｏｍｐａｎｙ 軸受の構成要素を形成する方法
AU2016374425B2 (en) * 2015-12-18 2021-10-21 3-D Matrix, Ltd. Hemostatic composition and hemostatic method using hemostatic composition
WO2017120092A1 (en) 2016-01-06 2017-07-13 3-D Matrix, Ltd. Combination compositions
MX2018011121A (es) * 2016-03-18 2019-01-31 3 D Matrix Ltd Prevención de la adherencia de tejido biológico.
US20200078489A1 (en) * 2016-03-18 2020-03-12 3-D Matrix, Ltd. Pancreatic fistula occlusion
BR112018068939A2 (pt) * 2016-03-18 2019-01-22 3 D Matrix Ltd oclusão de vazamento de fluido cérebro-espinhal
EP3248591A1 (en) 2016-05-24 2017-11-29 Credentis AG Method and product for caries treatment
EP3248590A1 (en) 2016-05-24 2017-11-29 Credentis AG Personal dental care product for caries treatment
CA3026239A1 (en) * 2016-06-01 2017-12-07 3-D Matrix, Ltd. Hemostatic powders with self-assembling peptide hydrogels
EP3463495A1 (en) * 2016-06-01 2019-04-10 3-D Matrix Ltd. Hemostatic dressings with self-assembling peptide hydrogels
JP7012950B2 (ja) * 2016-11-17 2022-01-31 地方独立行政法人東京都立産業技術研究センター 生体組織孔閉鎖用、潰瘍保護用及び血管塞栓療術用ゾル
US11174288B2 (en) 2016-12-06 2021-11-16 Northeastern University Heparin-binding cationic peptide self-assembling peptide amphiphiles useful against drug-resistant bacteria
CN117085140A (zh) 2017-12-15 2023-11-21 立美基股份有限公司 表面活性剂肽纳米结构及在药物递送中的用途
WO2020008377A2 (en) 2018-07-03 2020-01-09 3-D Matrix, Ltd. Ionic self-assembling peptides
EP3831360A1 (en) 2019-12-04 2021-06-09 Credentis AG Personal dental care product for preventing demineralisation
WO2021146291A1 (en) * 2020-01-13 2021-07-22 Arch Biosurgery, Inc. Self-assembling peptide gel formulation and methods of use
WO2021202577A1 (en) 2020-03-31 2021-10-07 3-D Matrix, Ltd. Sterilization of self-assembling peptides by irradiation
US11154470B1 (en) 2020-07-31 2021-10-26 vVardis AG Anti-inflammatory and senolytic dental care product with tooth whitening characteristics
CN111848736B (zh) * 2020-08-05 2021-12-31 赛克赛斯生物科技股份有限公司 自组装多肽、制备方法、自组装多肽制剂及应用
CN111939323B (zh) * 2020-08-08 2022-06-10 武汉速普生物科技有限公司 含有透明质酸连接肽和连接蛋白末端肽的功能性多肽水凝胶及其应用
EP3957338A1 (en) 2020-08-20 2022-02-23 Aobakasei Kabushiki Kaisha Liquid medical material

Family Cites Families (89)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4582640A (en) 1982-03-08 1986-04-15 Collagen Corporation Injectable cross-linked collagen implant material
US4642117A (en) 1985-03-22 1987-02-10 Collagen Corporation Mechanically sheared collagen implant material and method
US4947840A (en) 1987-08-21 1990-08-14 Massachusetts Institute Of Technology Biodegradable templates for the regeneration of tissues
US5236903A (en) 1988-06-24 1993-08-17 Ichiro Azuma Polypeptide comprising repeated cell-adhesive core sequences
US5110604A (en) 1988-06-30 1992-05-05 Collagen Corporation Processes for producing collagen matrixes and methods of using same
US5126141A (en) 1988-11-16 1992-06-30 Mediventures Incorporated Composition and method for post-surgical adhesion reduction with thermo-irreversible gels of polyoxyalkylene polymers and ionic polysaccharides
US5550187A (en) 1988-11-21 1996-08-27 Collagen Corporation Method of preparing crosslinked biomaterial compositions for use in tissue augmentation
US5629291A (en) 1992-01-31 1997-05-13 La Jolla Cancer Research Foundation Methods of modulating fibronectin extracellular matrix assembly
US5292514A (en) 1992-06-24 1994-03-08 Minnesota Mining And Manufacturing Company Azlactone-functional substrates, corneal prostheses, and manufacture and use thereof
US5955343A (en) 1992-12-28 1999-09-21 Massachusetts Institute Of Technology Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor
US5670483A (en) 1992-12-28 1997-09-23 Massachusetts Insititute Of Technology Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor
GB2274988A (en) * 1993-02-10 1994-08-17 Mcconn Stern Rita Iodine containing wound-healing preparations
US5709854A (en) 1993-04-30 1998-01-20 Massachusetts Institute Of Technology Tissue formation by injecting a cell-polymeric solution that gels in vivo
US5773577A (en) 1994-03-03 1998-06-30 Protein Polymer Technologies Products comprising substrates capable of enzymatic cross-linking
US5527610A (en) 1994-05-20 1996-06-18 The Uab Research Foundation Elastomeric polypeptide matrices for preventing adhesion of biological materials
US5510102A (en) 1995-01-23 1996-04-23 The Regents Of The University Of California Plasma and polymer containing surgical hemostatic adhesives
AU5638096A (en) 1995-06-07 1996-12-30 Clarion Pharmaceuticals, Inc. Non-biological patch for hemostasis
JP2000510357A (ja) 1996-04-04 2000-08-15 イムノ・アクチエンゲゼルシャフト コラーゲンを基にした止血スポンジ
US6489446B1 (en) 1996-08-07 2002-12-03 Hsc Research And Development Limited Partnership Self-aligning peptides modeled on human elastin and other fibrous proteins
WO1998030141A2 (en) 1997-01-09 1998-07-16 Cohesion Technologies, Inc. Devices for tissue repair and methods for preparation and use thereof
US6224893B1 (en) 1997-04-11 2001-05-01 Massachusetts Institute Of Technology Semi-interpenetrating or interpenetrating polymer networks for drug delivery and tissue engineering
US6228324B1 (en) 1997-11-28 2001-05-08 Seikagaku Corporation Sterilizing method for medical sterilization packaging and injection pack
US6187555B1 (en) 1998-04-16 2001-02-13 3M Innovative Properties Company Spores with increased sensitivity to sterilants using additives that bind to sterilant-sensitive sites
ATE282959T1 (de) 1998-07-06 2004-12-15 Nanobac Oy Verfahren zur beseitigung von nanobakterien
US6046160A (en) 1999-07-22 2000-04-04 Deroyal Industries, Inc. Composition and method for enhancing wound healing
EP1282437B1 (en) * 2000-05-16 2008-03-19 Genentech, Inc. Treatment of cartilage disorders
WO2002022072A2 (en) 2000-09-11 2002-03-21 Closure Medical Corporation Bronchial occlusion method and apparatus
MXPA03006689A (es) 2001-01-25 2004-03-12 Nycomed Pharma As Una suspension que comprende fibrinogeno, trombina y alcohol, un metodo para preparar dicha suspension, un metodo para recubrir un soporte con dicha suspension, un metodo de secado de un recubrimiento de un soporte, y una esponja de colageno recubier
US7449180B2 (en) 2001-02-06 2008-11-11 John Kisiday Macroscopic scaffold containing amphiphilic peptides encapsulating cells
WO2002062969A2 (en) 2001-02-06 2002-08-15 Massachusetts Institute Of Technology Cellular reprogramming in peptide hydrogel and uses thereof
WO2002090503A2 (en) 2001-05-04 2002-11-14 The Scripps Research Institute Anti-microbial peptides and compositions
AU2003222167A1 (en) 2002-04-02 2003-10-20 Northwestern University Peptide amphiphile solutions and self assembled peptide nanofiber networks
US20040242469A1 (en) 2002-05-13 2004-12-02 Lee Richard T. Angiogenesis and cardiac tissue engineering with peptide hydrogels and related compositions and methods of use thereof
GB0216286D0 (en) 2002-07-15 2002-08-21 Univ Leeds Network
WO2004013161A2 (en) 2002-08-06 2004-02-12 Epix Pharmaceuticals, Inc. Peptide aggregates
US7713923B2 (en) 2003-06-25 2010-05-11 Massachusetts Institute Of Technology Self-assembling peptides incorporating modifications and methods of use thereof
EP1636250B1 (en) 2003-06-25 2016-01-06 Massachusetts Institute Of Technology Self-assembling peptides incorporating modifications and uses thereof
EP2338980B1 (en) 2003-06-27 2015-04-22 DePuy Synthes Products, LLC Regeneration and repair of neural tissue using postpartum umbilical cord -derived cells
US7846891B2 (en) 2003-10-17 2010-12-07 Massachusetts Institute Of Technology Self-assembling peptides for regeneration and repair of neural tissue
GB0404374D0 (en) 2004-02-27 2004-03-31 Univ Manchester Treatment of bacterial infections
JP2005263631A (ja) 2004-03-16 2005-09-29 Sanyo Chem Ind Ltd 細胞接着性ポリペプチド
US20050266086A1 (en) 2004-06-01 2005-12-01 Sawhney Amarpreet S Intrauterine applications of materials formed in situ
EP3031466B1 (en) 2004-07-06 2018-11-28 3D Matrix, Inc. Purified amphiphilic peptide compositions and uses thereof
WO2006016524A1 (ja) 2004-08-11 2006-02-16 Pioneer Corporation 外部制御記録再生システム
JP2008526749A (ja) 2005-01-04 2008-07-24 ザ ブライハム アンド ウイメンズ ホスピタル， インコーポレイテッド 自己アセンブリするペプチドナノファイバーを用いたｐｄｇｆの徐放性の送達
US9162005B2 (en) * 2005-04-25 2015-10-20 Arch Biosurgery, Inc. Compositions for prevention of adhesions and other barrier applications
US9327010B2 (en) 2005-04-25 2016-05-03 Massachusetts Institute Of Technology Compositions and methods for promoting hemostasis and other physiological activities
US20060293243A1 (en) 2005-06-17 2006-12-28 Navneet Puri Stable, buffered, pharmaceutical compositions including motilin-like peptides
CN101198350A (zh) 2005-06-17 2008-06-11 巴克斯特国际公司 含胃动素样肽的稳定的缓冲的药物组合物
JP2008546689A (ja) 2005-06-17 2008-12-25 バクスター・インターナショナル・インコーポレイテッド モチリン様ペプチドを含む、安定に緩衝化された薬学的組成物
JP4982841B2 (ja) 2005-10-12 2012-07-25 国立大学法人名古屋大学 再生医療骨組成物
CA2629897A1 (en) 2005-11-14 2007-05-24 Ud Technology Corporation Novel hydrogels and uses thereof
TW201008595A (en) 2005-12-20 2010-03-01 Bristol Myers Squibb Co Stable protein formulations
ES2439641T3 (es) 2005-12-20 2014-01-24 Bristol-Myers Squibb Company Composiciones y procedimientos de producción de una composición
US9095818B2 (en) 2009-06-15 2015-08-04 Biovec Transfusion, Llc Method of filtering platelets to remove antiplatelet and anticoagulant agents
CA2650230C (en) 2006-04-25 2017-01-10 Massachusetts Institute Of Technology Compositions and methods for affecting movement of contaminants, bodily fluids or other entities, and/or affecting other physiological conditions
JP5496671B2 (ja) * 2006-09-26 2014-05-21 マサチューセッツ インスティテュート オブ テクノロジー 修飾自己組織化ペプチド
US9012404B2 (en) 2006-12-11 2015-04-21 3D Matrix, Inc. Compositions and methods for cardiac tissue protection and regeneration
CA2680824C (en) 2007-03-14 2018-06-26 Arch Therapeutics, Inc. Treatment of leaky or damaged tight junctions and enhancing extracellular matrix
EP2146667A2 (en) 2007-04-11 2010-01-27 Henry Ford Health System Cardiac repair, resizing and reshaping using the venous system of the heart
JP2009011341A (ja) 2007-06-29 2009-01-22 Yuka Denshi Co Ltd ペースト状材料充填容器
US20090053103A1 (en) 2007-08-20 2009-02-26 William Patrick Mortimer Non-linting sterilization packaging material
US20110002880A1 (en) 2007-12-05 2011-01-06 3-D Matrix, Ltd. Material For Wound Healing and Skin Reconstruction
US8834926B2 (en) 2008-08-08 2014-09-16 University Of Delaware Macromolecular diffusion and release from self-assembled β-hairpin peptide hydrogels
CN105435211A (zh) 2008-10-06 2016-03-30 三维肽胶株式会社 组织闭塞剂
CN101514225B (zh) 2008-10-13 2011-09-14 西安蓝晶生物科技有限公司 自聚体多肽及其制备方法和应用
EP2407479B2 (en) 2009-03-09 2017-08-23 Menicon Co., Ltd. Self-assembling peptide and peptide gel with high strength
US20120070427A1 (en) 2009-06-01 2012-03-22 Trustees Of Tufts College Vortex-induced silk fibroin gelation for encapsulation and delivery
WO2011072482A1 (en) 2009-12-14 2011-06-23 The University Of Hong Kong Nano cancer barrier device(ncbd) to immobilize and inhibit the division of metastic cancer stem cells
JP5855651B2 (ja) 2010-07-16 2016-02-09 マサチューセッツ インスティテュート オブ テクノロジー 改変を組み込んだ自己組織化ペプチドおよびその使用方法
JP2012082180A (ja) 2010-10-14 2012-04-26 Nagoya Univ 骨再生用自己組織化ペプチドハイドロゲル
US20140329914A1 (en) 2011-09-02 2014-11-06 3-D Matrix Ltd. Amphiphilic Peptides for Thoracic Air Leakage Occlusion
US20150105336A1 (en) 2012-03-09 2015-04-16 3-D Matrix, Ltd. Mucosa-elevating agent
WO2014008400A2 (en) 2012-07-06 2014-01-09 3-D Matrix, Inc. Fill-finish process for peptide solutions
US9862916B2 (en) 2012-07-27 2018-01-09 Koninklijke Coöperatie Cosun U.A. Structuring agent for liquid detergent and personal care products
JP2016501066A (ja) 2012-11-14 2016-01-18 株式会社スリー・ディー・マトリックス 血管塞栓システム
CN103251690B (zh) 2013-02-26 2015-10-28 中国人民解放军新疆军区联勤部药品仪器检验所 维药瘤果黑种草子挥发油在制备治疗慢性阻塞性肺病药物的应用
WO2014136081A1 (en) 2013-03-06 2014-09-12 3D-Matrix Ltd. Surgical methods employing purified amphiphilic peptide compositions
CA2905182A1 (en) 2013-03-14 2014-09-18 3-D Matrix, Ltd. Materials for gastrointestinal obstruction prevention
JP2016513523A (ja) 2013-03-14 2016-05-16 株式会社スリー・ディー・マトリックス 胆汁漏の処置
JP6502352B2 (ja) 2013-08-22 2019-04-17 アーチ・バイオサージェリー・インコーポレイテッド 流体の移動を制御するための移植可能なメッシュ
ES2842101T3 (es) 2013-09-02 2021-07-12 Taisei Kako Co Jeringa y conjunto de jeringa
US10245299B2 (en) 2014-03-10 2019-04-02 3-D Matrix, Ltd. Autoassembling peptides for the treatment of pulmonary bulla
ES2706492T3 (es) 2014-03-10 2019-03-29 3 D Matrix Ltd Péptidos de autoensamblaje como agentes para la obstrucción bronquial
US10654893B2 (en) 2014-03-10 2020-05-19 3-D Matrix, Ltd. Self-assembling peptide compositions
WO2015138473A1 (en) 2014-03-10 2015-09-17 3-D Matrix, Ltd. Autoassembling peptides for the treatment of pulmonary leakage
WO2015136370A2 (en) 2014-03-10 2015-09-17 3-D Matrix, Ltd. Sterilization and filtration of peptide compositions
BR112016029518A2 (pt) 2014-06-20 2018-06-19 3-D Matrix, Ltd. materiais e métodos para o enchimento de cavidades ósseas
WO2017120092A1 (en) 2016-01-06 2017-07-13 3-D Matrix, Ltd. Combination compositions

Also Published As

Publication number Publication date
EP2345433A4 (en) 2013-12-25
RU2011118341A (ru) 2012-11-20
US20200222496A1 (en) 2020-07-16
JP6492137B2 (ja) 2019-03-27
WO2010041636A1 (ja) 2010-04-15
US20110201541A1 (en) 2011-08-18
US20220193184A1 (en) 2022-06-23
JP2018033954A (ja) 2018-03-08
EP4183425A1 (en) 2023-05-24
EP3800197B1 (en) 2022-09-28
US10576123B2 (en) 2020-03-03
PH12019502295A1 (en) 2021-03-01
US20140038909A1 (en) 2014-02-06
JP5922749B2 (ja) 2016-05-24
KR20110083648A (ko) 2011-07-20
PH12017501278B1 (en) 2018-03-12
JP2015077416A (ja) 2015-04-23
US10596225B2 (en) 2020-03-24
JP2016174912A (ja) 2016-10-06
BRPI0920030B1 (pt) 2019-03-26
ES2821436T3 (es) 2021-04-26
RU2016102347A (ru) 2018-11-20
EP3238749A1 (en) 2017-11-01
EP3800197A1 (en) 2021-04-07
EP3470093A1 (en) 2019-04-17
JP6200997B2 (ja) 2017-09-20
PH12017501278A1 (en) 2018-03-12
PL3470093T3 (pl) 2021-01-25
KR101670099B1 (ko) 2016-10-27
EP2345433B1 (en) 2017-03-01
BRPI0920030A2 (pt) 2015-12-15
EP2345433A1 (en) 2011-07-20
ES2624484T3 (es) 2017-07-14
JPWO2010041636A1 (ja) 2012-03-08
CN105435211A (zh) 2016-03-30
ES2694000T3 (es) 2018-12-17
EP3800197B8 (en) 2023-03-22
US20240115652A1 (en) 2024-04-11
EP3470093B1 (en) 2020-08-19
CN102170919A (zh) 2011-08-31
EP3238749B1 (en) 2018-09-19
US11801281B2 (en) 2023-10-31
SG194405A1 (en) 2013-11-29

Similar Documents

Publication Publication Date Title
HK1223025A1 (zh) 組織閉塞劑
EP2328489A4 (en) DEVICE FOR TISSUE MODIFICATION
EP2234545A4 (en) GEWEBELIGATURVORRICHTUNG
AU320819S (en) Surgical spatula
EP2280649A4 (en) FABRIC CARRIER OXYMETER
EP2265189A4 (en) FABRIC CLAMP
GB2476842B (en) Forceps
GB0808711D0 (en) Tissue assessment
IL220526A0 (en) Kokumi-imparting agent
EP2478768A4 (en) ANTIPHYTOVIRAL AGENT
PL2237727T3 (pl) Retraktor tkanek
IL211073A0 (en) Surgical endoscope
IL220527A0 (en) Kokumi-imparting agent
GB0821097D0 (en) Surgical device
ZA201006996B (en) Firefighting unit
EP2433502A4 (en) AGENT FOR REMOVING AMERTUME
GB0900484D0 (en) Therapeutic agent
EP2434290A4 (en) AGENT EXTENDING BLOOD COAGULATION TIME
GB0820117D0 (en) Tourniquet
EP2285290A4 (en) FABRIC RETENTION SYSTEM
PL386453A1 (pl) Środek gaśniczy
GB0800265D0 (en) Tissue monitor
GB0809820D0 (en) Modified tissues
GB0800003D0 (en) Surgical retractor
AU323310S (en) Tissue dispenser